Co-Occurrence of Cytogenetic Abnormalities and High-Risk Disease in Newly Diagnosed and Relapsed/Refractory Multiple MyelomaMartin Kaiser, Niels Weinhold, Pieter Sonneveld et al.|Journal of Clinical Oncology|2025Cited by 17
Proof of the Concept to Use a Malignant B Cell Line Drug Screen Strategy for Identification and Weight of Melphalan Resistance Genes in Multiple MyelomaMartin Bøgsted, Hans Erik Johnsen, Malene Krag Kjeldsen et al.|PLoS ONE|2013Cited by 15
A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosisJulie Støve Bødker, Martin Bøgsted, Rasmus Froberg Brøndum et al.|Blood Advances|2018Cited by 6